- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05763303
Impact of an Interventional Program on Self-Management
June 5, 2025 updated by: Ramadan Ali Hamza, Assiut University
Impact of an Interventional Program on Self-Management Among Students With Diabetes in Assiut University
The goal of this randomized clinical trial study is to assess the effect of an interventional program on diabetes self-management and therefore on effective glycemic control among diabetic students in Assuit university
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
- To formulate a strategy aiming to reduce the burden of diabetes morbidity & mortality;
- To determine degree of self-management in diabetic participants
- To identify the obstacles facing the diabetic students to achieve an accepted self-management;
- To assess the impact of the interventional program on overcoming such obstacles; and
- To assess the impact of diabetes self-management on glycemic control among diabetic students in Assiut University All university students who suffer from diabetes and attend the study's clinic seeking medical treatment during a full academic year (2023/2024) with inclusion and exclusion criteria are recruited. The sample is divided into 150 cases for intervention group and 150 for control group (traditional care), by Systemic random technique. All participants will be exposed to Questionnaires for assessment of Diabetes Self-management, and measurements of glycated hemoglobin (HbA1c), body weight, height, at base line, three months, and 6 months after the end of the program.
Study Type
Interventional
Enrollment (Estimated)
300
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Ramadan Ai, Investigato
- Phone Number: 01112586630
- Email: alidrrmadan@yahoo.com
Study Contact Backup
- Name: Medhat Araby, Chair
- Phone Number: 01000032910
- Email: Medhatelaraby75@yahoo.com
Study Locations
-
-
-
Asyut, Egypt
- Recruiting
- faculty of medicine / Assiut university
-
Contact:
- Ramadan Ali
- Phone Number: 01112586630
- Email: alidrramadan@yahoo.com
-
Contact:
- Medhat Araby, proph
- Phone Number: 01000032910
- Email: Medhatelaraby75@yahoo.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
•Confirmed cases of diabetes mellitus (IDD" type I" & NIDD "type II") among Assiut University students
Exclusion Criteria:
- Diabetic students with severe disability or handicapped
- Diabetic students known to have another health problem make him un tolerable to do exercise such as cardiovascular disease, bronchial asthma
- Diabetic students with speech and hearing difficulties.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: control group
traditional care: the participants will received traditional care in health facility but nothing by researcher
|
interventional program consists of educational part and training part in case of agreement of participants
|
|
Experimental: intervention group
received interventional program which will consist of :
|
interventional program consists of educational part and training part in case of agreement of participants
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
assessment of change in Perceived Obstacles to diabetes self-management that faced by participants
Time Frame: at base line, three months and six months after the end of the program.
|
by short version of the diabetic obstacle questionnaire.
|
at base line, three months and six months after the end of the program.
|
|
assessment of Change in Diabetes Self-management
Time Frame: at base line, three months and six months after the end of the program.
|
by diabetes self-management questionnaire,
|
at base line, three months and six months after the end of the program.
|
|
assessment of change in measurements of glycated hemoglobin (HbA1c)
Time Frame: at base line, three months and six months after the end of the program.
|
by blood analysis to measure (HbA1c)
|
at base line, three months and six months after the end of the program.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
assessment of change in measurement of body mass index (BMI)
Time Frame: at base line, three months and six months after the end of the program.
|
by measurement of weight in kilograms and height in meters and use formula: (BMI) = weight in kilograms ÷ ( height in meter × height in meter)
|
at base line, three months and six months after the end of the program.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Chair: Mohammad Hassan Qayed, Chair, Assiut University
- Study Director: Manal El-Sayed EzzEl-Dine Abdel-Mooty, director, Internal Medicine - Assiut faculty of Medicine
- Study Director: Emad Shaban Ali Hassan, director, Department of Sports Health Sciences, Faculty of Physical Education
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 25, 2023
Primary Completion (Estimated)
September 15, 2025
Study Completion (Estimated)
October 1, 2025
Study Registration Dates
First Submitted
February 10, 2023
First Submitted That Met QC Criteria
March 8, 2023
First Posted (Actual)
March 10, 2023
Study Record Updates
Last Update Posted (Actual)
June 8, 2025
Last Update Submitted That Met QC Criteria
June 5, 2025
Last Verified
June 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Diabetes Self Management
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.